Results at 43 months' follow-up of a double-blind, randomized, prospective clinical trial using intravesical interferon alpha-2b in the prophylaxis of stage pt1 transitional cell carcinoma of the bladder

Author: Portillo J.   Martin B.   Hernandez R.   Correas M.   Gutierrez J.   del Valle J.   Roca A.   Vega A.   Villanueva A.   Gutierrez R.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.49, Iss.2, 1997-02, pp. : 187-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content